OtherAccelerated Communication
Glucuronidation Converts Gemfibrozil to a Potent, Metabolism-Dependent Inhibitor of CYP2C8: Implications for Drug-Drug Interactions
Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
Drug Metabolism and Disposition November 18, 2005, DOI: https://doi.org/10.1124/dmd.105.007633
Brian W. Ogilvie
Donglu Zhang
Wenying Li
A. David Rodrigues
Amy E. Gipson
Jeff Holsapple
Paul Toren
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherAccelerated Communication
Glucuronidation Converts Gemfibrozil to a Potent, Metabolism-Dependent Inhibitor of CYP2C8: Implications for Drug-Drug Interactions
Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
Drug Metabolism and Disposition November 18, 2005, DOI: https://doi.org/10.1124/dmd.105.007633
OtherAccelerated Communication
Glucuronidation Converts Gemfibrozil to a Potent, Metabolism-Dependent Inhibitor of CYP2C8: Implications for Drug-Drug Interactions
Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
Drug Metabolism and Disposition November 18, 2005, DOI: https://doi.org/10.1124/dmd.105.007633
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement